MPM BioImpact’s Odyssey Therapeutics ODTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ODTX
MPM BioImpact's ODTX Position: Q3 2026 in Review
MPM BioImpact opened a new position in Odyssey Therapeutics (ODTX) in Q3 2026: 1,289,091 shares worth $28.6M. The stake represents 2.13% of the portfolio and ranks #22 among its holdings.
72 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.
- MPM BioImpact held 1,289,091 shares of Odyssey Therapeutics worth $28.6M as of Q3 2026.
- Odyssey Therapeutics was a new MPM BioImpact position in Q3 2026.
- Odyssey Therapeutics made up 2.13% of MPM BioImpact's portfolio in Q3 2026, its #22 holding.
- 72 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.
Based on MPM BioImpact's 13F filing for Q3 2026, filed 16 Nov 2026.